{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-26-001866","form_type":"8-K","ticker":"GALT","cik":"0001133416","company_name":"GALECTIN THERAPEUTICS INC","filed_at":"2026-01-21T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.600565+00:00","generated_at":"2026-05-16T09:13:15.732753+00:00","sec_items":["5.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Galectin Therapeutics approves $450k in retention bonuses for CMO and CFO","bullets":["Board approves $300,000 cash retention bonus for CMO Dr. Khurram Jamil.","Board approves $150,000 cash retention bonus for CFO Jack Callicutt.","Bonuses payable in three equal installments on June 1, Sep 1, Dec 1, 2026.","Bonuses require repayment if officers voluntarily resign without good reason or are terminated for cause before Dec 31, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-001866","json":"https://secwatch.observer/filing/0001140361-26-001866.json","markdown":"https://secwatch.observer/filing/0001140361-26-001866.md","text":"https://secwatch.observer/filing/0001140361-26-001866.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1133416/000114036126001866/0001140361-26-001866-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1133416/000114036126001866/ef20063365_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T09:13:15.732753+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}